Ligand validation:2VLH

P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VLH_P33_A_1460	10%	78%	0.313	0.816	0.55	0.36	-	-	2	0	100%	1
6MLS_P33_B_1601	6%	78%	0.185	0.621	0.55	0.35	-	-	2	0	100%	1
6MPD_P33_B_1601	2%	85%	0.261	0.536	0.54	0.22	-	-	0	0	100%	1
5L2V_P33_A_202	81%	60%	0.11	0.962	0.46	1.06	-	1	0	0	100%	0.5
3B1Q_P33_A_331	70%	50%	0.106	0.922	0.6	1.3	-	3	4	0	100%	1
8BK2_P33_L_301	66%	70%	0.121	0.926	0.53	0.63	-	1	3	0	100%	1
8CCQ_P33_A_2013	65%	66%	0.113	0.914	0.58	0.74	-	-	2	0	100%	1
2Y2U_P33_B_1545	64%	47%	0.146	0.963	0.52	1.49	-	1	3	0	91%	0.9091

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.